908 Devices Inc.
908 Devices Inc. (MASS) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for 908 Devices Inc. (MASS), featuring income statements, balance sheets, and cash flow data.
908 Devices Inc. (MASS) Income Statement & Financial Overview
Review 908 Devices Inc. MASS income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $13.04M | $11.78M | $18.82M | $16.77M |
| Cost of Revenue | $6.66M | $6.24M | $9.72M | $8.44M |
| Gross Profit | $6.37M | $5.54M | $9.10M | $8.33M |
| Gross Profit Ratio | $0.49 | $0.47 | $0.48 | $0.50 |
| R&D Expenses | $4.41M | $3.83M | $6.54M | $6.79M |
| SG&A Expenses | $10.34M | $10.24M | $13.76M | $13.38M |
| Operating Expenses | $14.87M | $14.07M | $29.36M | $38.55M |
| Total Costs & Expenses | $21.53M | $20.30M | $39.07M | $46.99M |
| Interest Income | $1.20M | $816000.00 | $753000.00 | $879000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $1.29M | $1.42M | $1.41M |
| EBITDA | -$15.16M | -$7.24M | -$18.10M | -$27.95M |
| EBITDA Ratio | -$1.16 | -$0.61 | -$0.96 | -$1.67 |
| Operating Income | -$15.16M | -$11.03M | -$20.25M | -$30.22M |
| Operating Income Ratio | -$1.16 | -$0.94 | -$1.08 | -$1.80 |
| Other Income/Expenses (Net) | $2.32M | $54.63M | $736000.00 | $850000.00 |
| Income Before Tax | -$12.84M | $43.60M | -$19.52M | -$29.37M |
| Income Before Tax Ratio | -$0.98 | $3.70 | -$1.04 | -$1.75 |
| Income Tax Expense | -$71000.00 | $0.00 | -$71000.00 | -$72000.00 |
| Net Income | -$13.31M | $43.60M | -$19.45M | -$29.30M |
| Net Income Ratio | -$1.02 | $3.70 | -$1.03 | -$1.75 |
| EPS | -$0.37 | $1.23 | -$0.57 | -$0.84 |
| Diluted EPS | -$0.37 | $1.23 | -$0.57 | -$0.84 |
| Weighted Avg Shares Outstanding | $35.88M | $35.39M | $34.67M | $34.67M |
| Weighted Avg Shares Outstanding (Diluted) | $35.88M | $35.39M | $34.67M | $34.67M |
Over the last four quarters, 908 Devices Inc. achieved steady financial progress, growing revenue from $16.77M in Q3 2024 to $13.04M in Q2 2025. Gross profit stayed firm with margins at 49% in Q2 2025 versus 50% in Q3 2024. Operating income totaled -$15.16M in Q2 2025, maintaining a -116% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$15.16M. Net income dropped to -$13.31M, with EPS at -$0.37. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan